<DOC>
	<DOCNO>NCT01219413</DOCNO>
	<brief_summary>To evaluate proteinuria lower efficacy well tolerability safety renin inhibitor aliskiren compare placebo angiotensin convert enzyme inhibitor perindopril patient non-diabetic chronic renal disease .</brief_summary>
	<brief_title>Influence Aliskiren Proteinuria</brief_title>
	<detailed_description>Proteinuria major risk factor progression end-stage renal disease diabetic nondiabetic nephropathy . Angiotensin II aldosterone key player development renal failure , either directly promote tissue fibrosis indirectly action glomerular hemodynamic proteinuria . Therefore , pharmacological inhibition renin-angiotensin-aldosterone system ( RAAS ) may beneficial impact proteinuria chronic kidney disease progression . Recently , renin inhibitor , new class drug selectively inhibit angiotensin II formation first step RAAS cascade introduce clinical practice . Aliskiren first orally bioavailable direct renin inhibitor approve treatment hypertension . Blood pressure ( BP ) -lowering effect aliskiren associate decreased generation angiotensin I , block generation angiotensinogen , inhibit active enzymatic site renin . The investigator plan study evaluate short-term effect treatment aliskiren placebo ACEI perindopril proteinuria .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Perindopril</mesh_term>
	<criteria>age 1865 year chronic nondiabetic proteinuric nephropathy creatinine clearance 30 ml/min stable proteinuria 500 mg/ 24 hour blood pressure 125/75 mmHg 150/95 mmHg steroid immunosuppressive treatment minimum six month study unstable coronary heart disease decompensated congestive heart failure previous 6 month episode malignant hypertension stroke history diabetes creatinine clearance 30 ml/min</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>aliskiren</keyword>
	<keyword>renin inhibitor</keyword>
	<keyword>proteinuria</keyword>
	<keyword>chronic kidney disease</keyword>
	<keyword>ACE inhibitor</keyword>
</DOC>